Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Berretta, Andresa Aparecida ^a,b   De Castro, Patrícia Alves ^a   Cavalheiro, Amanda Henriques ^b   Fortes, Vanessa Silveira ^b   Bom, Vinícius Pedro ^a   Nascimento, Andresa Piacezzi ^b   Marquele Oliveira, Franciane ^b   Pedrazzi, Vinícius ^a   Ramalho, Leandra Naira Zambelli ^a   Goldman, Gustavo Henrique ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Apis Flora Industrial e Comercial LTDA   (Brazil)

^c BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICAFFEOYLQUINIC ACID; ANTIFUNGAL AGENT; AROMADENDRIN; CAFFEIC ACID; CARBOMER; CHITOSAN; CINNAMIC ACID; CLOTRIMAZOLE; COUMARIC ACID; GALLIC ACID; ISOCHLOROGENIC ACID; ISOSAKURANETIN; PARA COUMARIC ACID; PHENOL DERIVATIVE; POLOXAMER; PROPOLIS; QUINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FUNGICIDAL ACTIVITY; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MORPHOTYPE; MOUSE; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; VAGINA CANDIDIASIS;

EID: 84883157676     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/641480     Document Type: Article

References (54)

1. Sobel J. D., Vulvovaginal candidosis. Lancet 2007 369 9577 1961 1971 2-s2.0-34249895255 10.1016/S0140-6736(07)60917-9
2. Fidel P. L. Jr., Vaginal candidiasis: review and role of local mucosal immunity. AIDS Patient Care and STDs 1998 12 5 359 366 2-s2.0-0344333468
3. Naglik J. R., Challacombe S. J., Hube B., Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiology and Molecular Biology Reviews 2003 67 3 400 428 2-s2.0-0141789642 10.1128/MMBR.67.3.400-428. 2003
4. Fidel P. L. Jr., Cutright J. L., Sobel J. D., Efficacy of D0870 treatment of experimental Candida vaginitis. Antimicrobial Agents and Chemotherapy 1997 41 7 1455 1459 2-s2.0-0343472052
5. Lotz H., Brunner H., Rupp S., Hyphae-specific cell wall proteins of Candida. US2007/0196378A1, 2007
6. Perea S., López-Ribot J. L., Kirkpatrick W. R., McAtee R. K., Santillán R. A., Martínez M., Calabrese D., Sanglard D., Patterson T. F., Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy 2001 45 10 2676 2684 2-s2.0-0034812585 10.1128/AAC.45.10.2676-2684.2001
7. Pfaller M. A., Diekema D. J., Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. Journal of Clinical Microbiology 2004 42 10 4419 4431 2-s2.0-5444272819 10.1128/JCM.42.10.4419-4431.2004
8. Rocha B. A., Rodrigues M. R., Bueno P. C. P., De Mello Costa-Machado A. R., De Oliveira Lima Leite Vaz M. M., Nascimento A. P., Barud H. S., Berretta-Silva A. A., Preparation and thermal characterization of inclusion complex of Brazilian green propolis and hydroxypropyl- β -cyclodextrin: increased water solubility of the chemical constituents and antioxidant activity. Journal of Thermal Analysis and Calorimetry 2012 108 1 87 94 2-s2.0-84858073823 10.1007/s10973-011-1713-4
9. Volpi N., Bergonzini G., Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2006 42 3 354 361 2-s2.0-33748136868 10.1016/j.jpba.2006.04.017
10. Bruschi M. L., Jones D. S., Panzeri H., Gremião M. P. D., De Freitas O., Lara E. H. G., Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. Journal of Pharmaceutical Sciences 2007 96 8 2074 2089 2-s2.0-34548037865 10.1002/jps.20843
11. Andrews G. P., Laverty T. P., Jones D. S., Mucoadhesive polymeric platforms for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2009 71 3 505 518 2-s2.0-60749111451 10.1016/j.ejpb.2008.09.028
12. de Sousa J. P. B., Bueno P. C. P., Gregório L. E., da Silva Filho A. A., Furtado N. A. J. C., de Sousa M. L., Bastos J. K., A reliable quantitative method for the analysis of phenolic compounds in Brazilian propolis by reverse phase high performance liquid chromatography. Journal of Separation Science 2007 30 16 2656 2665 2-s2.0-36448934531 10.1002/jssc.200700228
13. Berretta A. A., Nascimento A. P., Bueno P. C. P., Leite Vaz M. M. D. O. L., Marchetti J. M., Propolis standardized extract (EPP-AF), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds. International Journal of Biological Sciences 2012 8 4 512 521 2-s2.0-84859522503 10.7150/ijbs.3641
14. de Andrade U. V. C., Hartmann W., Funayama S., de Alencar S. M., Masson M. L., Propolis obtained by means of alkaline hydrolysis and action on Staphylococcus aureus. Ars Veterinaria 2009 25 3 151 154
15. Machado J. L., Assunção A. K. M., da Silva M. C. P., dos Reis A. S., Costa G. C., Arruda D. S., Rocha B. A., Vaz M. M. O. L.L., Paes A. M. A., Guerra R. N. M., Berretta A. A., do Nascimento F. R. F., Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity. Evidence-Based Complementary and Alternative Medicine 2012 2010 10 157652 10.1155/2012/157652
16. Gillum A. M., Tsay E. Y. H., Kirsch D. R., Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Molecular and General Genetics 1984 198 1 179 182 2-s2.0-0021742042
17. Fonzi W. A., Irwin M. Y., Investigations-isogenic strain construction and gene mapping in Candida albicans. Genetics 1993 134 3 717 728 2-s2.0-0027192868
18. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard 2008 3rd CLSI document M27-A3
19. Yano J., Fidel P. L. Jr., Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. Journal of Visualized Experiments 2011 58, article 3382 10.3791/3382 2-s2.0-84857127355
20. Urushisaki T., Takemura T., Tazawa S., Fukuoka M., Hosokawa-Muto J., Araki Y., Kuwata K., Caffeoylquinic acids are major constituents with potent anti-influenza effects in brazilian green propolis water extract. Evidence-Based Complementary and Alternative Medicine 2011 2011 7 2-s2.0-79955093333 10.1155/2011/254914 254914
21. Andrade S. P., Moura S. A. L. D., Negri G., Salatino A., Lima L. D. D. C., Dourado L. P. A., Mendes J. B., Ferreira M. A. N. D., Cara D. C., Aqueous extract of Brazilian green propolis: primary components, evaluation of inflammation and wound healing by using subcutaneous implanted sponges. Evidence-Based Complementary and Alternative Medicine 2011 2011 8 2-s2.0-80052688425 10.1093/ecam/nep112 748283
22. Matsui T., Ebuchi S., Fujise T., Abesundara K. J. M., Doi S., Yamada H., Matsumoto K., Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caffeoylquinic acid. Biological and Pharmaceutical Bulletin 2004 27 11 1797 1803 2-s2.0-22044456421 10.1248/bpb.27.1797
23. de Castro P. A., Savoldi M., Bonatto D., Barros M. H., Goldman M. H. S., Berretta A. A., Goldman G. H., Molecular characterization of propolis-induced cell death in Saccharomyces cerevisiae. Eukaryotic Cell 2011 10 3 398 411 2-s2.0-79952299057 10.1128/EC.00256-10
24. Kofuji K., Ito T., Murata Y., Kawashima S., Biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice. Biological and Pharmaceutical Bulletin 2001 24 2 205 208 2-s2.0-0035113002 10.1248/bpb.24.205
25. Murata Y., Toniwa S., Miyamoto E., Kawashima S., Preparation of alginate gel beads containing chitosan salt and their function. International Journal of Pharmaceutics 1999 176 2 265 268 2-s2.0-0032962670 10.1016/S0378-5173(98)00308-1
26. Xuan J. J., Balakrishnan P., Oh D. H., Yeo W. H., Park S. M., Yong C. S., Choi H. G., Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. International Journal of Pharmaceutics 2010 395 1-2 317 323 2-s2.0-77954316122 10.1016/j.ijpharm.2010.05.042
27. Cid Y. P., Pedrazzi V., de Sousa V. P., Pierre M. B. R., In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. Amercian Association of Pharmaceutical Scientists 2012 13 1 101 111 2-s2.0-82755187741 10.1208/s12249-011-9725-8
28. Das Neves J., Da Silva M. V., Gonçalves M. P., Amaral M. H., Bahia M. F., Rheological properties of vaginal hydrophilic polymer gels. Current Drug Delivery 2009 6 1 83 92 2-s2.0-61849103596 10.2174/156720109787048294
29. Gaspar L. R., Maia Campos P. M. B. G., Rheological behavior and the SPF of sunscreens. International Journal of Pharmaceutics 2003 250 1 35 44 2-s2.0-0037413363 10.1016/S0378-5173(02)00462-3
30. Martin A., Physical Pharmacy 1993 4th Philadelphia, Pa, USA Lea & Febiger
31. A A., Berretta, Desenvolvimento e avaliação de uma forma farmacêutica de liberação sustentada contendo extrato padronizado de própolis para o tratamento de queimaduras [dissertação de mestrado] 2003 São Paulo, Brazil Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo
32. Ricci E. J., Bentley M. V. L. B., Farah M., Bretas R. E. S., Marchetti J. M., Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. European Journal of Pharmaceutical Sciences 2002 17 3 161 167 2-s2.0-0036829721 10.1016/S0928-0987(02)00166-5
33. Andrews G. P., Jones D. S., Rheological characterization of bioadhesive binary polymeric systems designed as platforms for drug delivery implants. Biomacromolecules 2006 7 3 899 906 2-s2.0-33645522443 10.1021/bm050620y
34. das Neves J., Bahia M. F., Review-gels as vaginal drug delivery systems. International Journal of Pharmaceutics 2006 318 1-2 1 14 2-s2.0-33745504777 10.1016/j.ijpharm.2006.03.012
35. Mikos A. G., Peppas N. A., Measurement of the surface tension of mucin solutions. International Journal of Pharmaceutics 1989 53 1 1 5 2-s2.0-0024390677
36. Burdock G. A., Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology 1998 36 4 347 363 2-s2.0-0032489791 10.1016/S0278-6915(97)00145-2
37. Rocha B. A., Bueno P. C. P., Vaz M. M. O. L. L., Nascimento A. P., Ferreira N. U., Moreno G. P., Rodrigues M. R., Costa-Machado A. R. M., Barizon E. A., Campos J. C. L., de Oliveira P. F., Acésio N. O., Martins S. L., Tavares D. C., Berretta A. A., Evaluation of a propolis water extract using a reliable RP-HPLC methodology and in vitro and in vivo efficacy and safety characterisation. Evidence-Based Complementary and Alternative Medicine 2013 2013 11 10.1155/2013/670451 670451
38. Bruschi M. L., Cardoso M. L. C., Lucchesi M. B., Gremião M. P. D., Gelatin microparticles containing propolis obtained by spray-drying technique: preparation and characterization. International Journal of Pharmaceutics 2003 264 1-2 45 55 2-s2.0-0142091819 10.1016/S0378-5173(03)00386-7
39. Bruschi M. L., Lara E. H. G., Martins C. H. G., Vinholis A. H. C., Casemiro L. A., Panzeri H., Gremião M. P. D., Preparation and antimicrobial activity of gelatin microparticles containing propolis against oral pathogens. Drug Development and Industrial Pharmacy 2006 32 2 229 238 2-s2.0-33645010971 10.1080/03639040500466312
40. Fernandes A. Jr., Balestrin E. C., Betoni J. E. C., De Oliveira Orsi R., De Souza Da Cunha M. D. L. R., Montelli A. C., Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Memorias do Instituto Oswaldo Cruz 2005 100 5 563 566 2-s2.0-26444517080
41. Longhini R., Raksa S. M., Oliveira A. C. P., Svidzinski T. I., Franco S. L., Obtenção de extratos de própolis sob diferentes condições e avaliação de sua atividade antifúngica. Revista Brasileira Farmacognosia 2007 17 3 388 395
42. Sawaya A. C. H. F., Palma A. M., Caetano F. M., Marcucci M. C., Da Silva Cunha I. B., Araujo C. E. P., Shimizu M. T., Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions against species of Candida. Letters in Applied Microbiology 2002 35 3 203 207 2-s2.0-0036041361 10.1046/j.1472-765X.2002.01169.x
43. Sikkema J., De Bont J. A. M., Poolman B., Mechanisms of membrane toxicity of hydrocarbons. Microbiological Reviews 1995 59 2 201 222 2-s2.0-0029048826
44. Brehm-Stecher B. F., Johnson E. A., Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrobial Agents and Chemotherapy 2003 47 10 3357 3360 2-s2.0-0141959252 10.1128/AAC.47.10.3357-3360.2003
45. Hornby J. M., Jensen E. C., Lisec A. D., Tasto J. J., Jahnke B., Shoemaker R., Dussault P., Nickerson K. W., Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Applied and Environmental Microbiology 2001 67 7 2982 2992 2-s2.0-0035406382 10.1128/AEM.67.7.2982-2992. 2001
46. Khutoryanskiy V. V., Advances in mucoadhesion and mucoadhesive polymers. Macromolecular Bioscience 2011 11 6 748 764 2-s2.0-79958174556 10.1002/mabi.201000388
47. Mortazavi S. A., Smart J. D., An investigation of some factors influencing the in vitro assessment of mucoadhesion. International Journal of Pharmaceutics 1995 116 2 223 230 2-s2.0-0028896195 10.1016/0378-5173(94)00299-K
48. Barry B. W., Recent advanced in pharmaceutical rheology. Journal of Texture Studies 2007 1 405 430
49. Perioli L., Ambrogi V., Venezia L., Pagano C., Ricci M., Rossi C., Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids and Surfaces B 2008 66 1 141 145 2-s2.0-47249159339 10.1016/j.colsurfb.2008.06.005
50. Henzl M. R., Properties of sustained-release single-dose formulations for vulvovaginal candidiasis: the example of butoconazole vaginal emulsion as a drug-sparing formulation. American Journal of Drug Delivery 2005 3 4 227 237 2-s2.0-31544434899 10.2165/00137696-200503040-00003
51. Scott V. R., Boehme R., Matthews T. R., New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrobial Agents and Chemotherapy 1988 32 8 1154 1157 2-s2.0-0023810585
52. González G. M., Portillo O. J., Uscanga G. I., Andrade S. E., Robledo M., Rodríguez C., Elizondo M., Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. Journal of Antimicrobial Chemotherapy 2009 64 3 571 573 2-s2.0-69049109918 10.1093/jac/dkp228
53. Stevens D. A., Calderon L., Martinez M., Clemons K. V., Wilson S. J., Selitrennikoff C. P., Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. Journal of Antimicrobial Chemotherapy 2002 50 3 361 364 2-s2.0-0036733522
54. Bachhav Y. G., Patravale V. B., Pharmaceutical nanotechnology- microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. International Journal of Pharmaceutics 2009 365 1-2 175 179 2-s2.0-57049181340 10.1016/j.ijpharm.2008.08.021